Analyst Ratings for Pyxis Oncology Inc. (PYXS)
PYXS Rating Summary
PYXS Price Target Summary
- Highest: $12.00 (Wells Fargo)
- Lowest: $5.00 (RBC Capital)
- Average: $7.56
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$7.56 (+119.6%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
Avg. $ Target:
$7.56 (+119.6%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/3/2026 | Wells Fargo | N/A | New Coverage | Overweight (N/A) |
12.00 (N/A) |
2.65 (3.44) |
29.81% | Details |
| 5/5/2026 | Wedbush | Robert Driscoll | New Coverage | Outperform (N/A) |
6.00 (N/A) |
1.76 (3.44) |
95.45% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
